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Background/Objectives: There is no consensus on the definition of sarcopenic obesity (SO), resulting in
inconsistent associations of SO with mortality risk. We aim to evaluate association of dual energy x-ray
absorptiometry (DXA) SO models with mortality risk in a US adult population (50 years).
Subjects/Methods: The study population consisted of 3577 participants aged 50 years and older from the
1999e2004 National Health and Nutrition and Examination Survey with mortality follow-up data
through December 31, 2011. Difference in survival time in people with and without SO defined by three
body composition DXA models (Model 1: body composition phenotype model; Model 2: Truncal Fat Mass
(TrFM)/Appendicular Skeletal Muscle Mass (ASM) ratio model; Model 3: Fat Mass (FM)/Fat Free Mass
(FFM) ratio). The differences between the models were assessed by the acceleration failure time model,
and expressed as time ratios (TR).
Results: Participants age 50e70 years with SO had a significantly decreased survival time, according to
the body composition phenotype model (TR: 0.92; 95% CI: 0.87e0.97), and TrFM/ASM ratio model (TR:
0.88; 95% CI: 0.81e0.95). The FM/FFM ratio model did not detect significant differences in survival time.
Participants with SO aged 70 years and older did not have a significantly decreased survival time, ac-
cording to all three models.
Conclusions: A SO phenotype increases mortality risk in people of age 50e70 years, but not in people
aged 70 years and older. The application of the body composition phenotype and the TrFM/ASM ratio
models may represent useful diagnostic approaches to improve the prediction of disease and mortality
risk.
© 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.1. Introduction
Body composition is influenced by different physiological and
non-physiological factors such as ageing, gender, diet and physicalinal and it has not been sub-
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al Health and Nutrition Examactivity, or acute and chronic illnesses [1]. These factors contribute to
shape the overall distribution of population body composition
phenotypes as they are key risk factors, amongst others, for
increased adiposity and loss of lean body mass [2e4] and ageing
may represent an important modifier of these reciprocal body
composition changes [5]. The net result of these biological, lifestyle
and demographic trends could be an increase in the prevalence of
the sarcopenic obesity (SO) phenotype, defined as the co-occurrence
of high adiposity and low lean body mass in the same individual [6].ism. All rights reserved.
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C. Van Aller et al. / Clinical Nutrition xxx (2018) 1e72Body Mass Index (BMI) is the most widely used indicator to
assess adiposity. However, a limitation of BMI is its inability to
distinguish the proportion of fat and lean body mass [7]. This
limitation can be overcome using different body composition
methods and dual energy x-ray absorptiometry (DXA) may offer
the best compromise to cost, accuracy and reproducibility [8].
DXA is currently considered as one of the most accurate body
composition methods for the assessment of SO [9]. However, there
is no consensus as yet on the definitions of SO [9e11]. Conse-
quently, the application of different definitions of SO has been an
important limiting factor in trying to establish its predictive role for
disease risk and mortality. Important drawbacks of many SO defi-
nitions are the lack of control for between-subject differences in
body mass, use of young populations as reference groups and
assessment of adiposity using anthropometric indexes (i.e., BMI,
waist circumference). The consequences of these differences are
the inconsistent association of SO with mortality in studies
reporting significant [12e18] and non-significant associations
[19,20].
Novel DXA models for the assessment of SO and other body
composition phenotypes have been proposed, which allow for the
control of the confounding effects of age, sex and BMI [21,22]. These
models were developed from DXA data of the U.S. National Health
and Nutrition Examination Survey (NHANES) 1999e2004. The aims
of these analyses are to verify if these newly proposed DXA models
are significant predictors of increased or decreased survival time in
a US adult population (age 50 years and older), if these models
predict survival time better than body mass index (BMI), and,
finally, to obtain more insights into the association between SO and
mortality risk.
2. Methods
2.1. NHANES
Datawere obtained from the NHANES 1999e2004. The NHANES
is a survey of the non-institutionalized civilian resident population
of the United States. A complex, multistage probability sampling
design was used to select a representative sample of 14,200 par-
ticipants [23]. The NHANES data on mortality for public use are
available continuously for the entire 1999e2004 period. Mortality
data were available from the date of survey participation to
December 31, 2011 [24] and the follow-up period ranged between 7
and 12 years. Mortality status is determined by conducting a
probabilistic pairing between NHANES and records of death cer-
tificates from the National Death Index. Detailed information about
NHANES and the mortality data can also be found elsewhere
[23,25]. For this analysis, participants weighing more than 136 kg,
taller than 1.96m (n¼ 3707), below 50 years of age (n¼ 6306), who
died in less than 24months after the baseline survey (n¼ 121), and
with missing data for household income level (n ¼ 470), average
daily physical activity level (n ¼ 10), education level (n ¼ 9), and
mortality status (n ¼ 7; total participants with missing data:
n ¼ 489) were excluded from the analysis. The final sample con-
sisted of 3577 participants.
2.2. DXA
Body composition assessment was undertaken by DXA (Hologic
QDR 4500A) [24]. Participants were not eligible for a DXA scan if
they were pregnant, weighed more than 136 kg and if they were
taller than 1.96 m. In addition, participants were not eligible if they
had been exposed to radiographic contrast material in the past 7
days or nuclear medicine in the past 3 days [24]. Complete DXA
data were obtained from 80% of the eligible participants [25]. DXAPlease cite this article in press as: Van Aller C, et al., Sarcopenic obesity a
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10.1016/j.clnu.2018.01.022data incompleteness was related to age, BMI, weight and height,
and multiple imputation of the missing data was performed by the
National Center for Health Statistics (NCHS). Five completed data
files containing both the non-missing and imputed DXA data values
were created [25].
2.3. BMI and DXA-models of body composition phenotypes
Nutritional status and body composition were defined to anal-
yse if subgroups based on these variables have an increased or
decreased survival time. Nutritional status was defined by BMI
(body weight/height2), and categorized for analysis as BMI
<25.0 kg/m2, 25.0e30.0 kg/m2 and 30.0 kg/m2. Body composition
and SO were assessed by three different models based on DXA data
[21,22]. These three approaches have in common that they divide
people into groups based on specific cut-points of muscle and fat
mass. The cut-points are defined from age-standardised reference
curves stratified by BMI and gender. The reference curves were
developed from non-imputed NHANES 1999e2004 DXA data of
13,236 participants above 18 years. The first approach, FM/FFM
model, was based on the ratio between total fat mass (FM) and total
fat free mass (FFM) [22]. The cut-off points of the reference curves
for this approach were as follows: a ratio below the 15th centile, in
the 15the85th centile, in the 85the95th centile or above the 95th
centile. The group with a FM/FFM ratio above the 95th centile are
considered as the SO group. The second approach, BC phenotype
model, divides people in four different body composition pheno-
types based on having lowadiposity (LA) or high adiposity (HA) and
low muscle mass (LM) or high muscle mass (HM) [21]. Participants
were defined as having low or high adiposity when the fat mass
index (total fat mass/height2) was below or above the 50th
percentile of the reference curve. The same applies for low or high
muscle mass, but then with reference curves of the appendicular
skeletal muscle index (lean soft tissue of the arms and legs/
height2). The group with HA and LM are considered as the SO
group. The third, and most specific approach at the regional
anatomic level, is the TrFM/ASM model. This approach was based
on the ratio between truncal fat mass (TrFM) and appendicular
skeletal muscle mass (ASM) [22], and similar to the FM/FFM model
approach. The only difference was in the body components used for
the calculation of the ratio. Assessment of body composition, ac-
cording to the approaches mentioned above, were performed with
an automated toolkit which can be made available upon request to
the corresponding author (MS). Detailed information about the
body composition models has been published previously [21,22].
2.4. Covariates
All covariates were self-reported. Ethnicity was classified as
non-Hispanic white, Mexican American, non-Hispanic black or
other ethnicity. Education level is the highest grade or level of
school completed or the highest degree received, and classified as
an education level lower than high school, high school, or higher
than high school. The smoking status of participants was divided in
smokers and non-smokers. Participants were classified as smoker if
they regularly (some days or every day) smoked cigarettes, cigars or
pipe or if they chewed tobacco. Average daily physical activity was
classified as participants sits a lot; stands or walks a lot; lift light
loads or climbs stairs or hills often; or does heavy work or carries
heavy loads.
2.5. Statistical analysis
Descriptive statistics are expressed as mean ± standard error
(continuous variables) or as percentages (categorical variables).nd overall mortality: Results from the application of novel models of
ination Survey 1999e2004, Clinical Nutrition (2018), https://doi.org/
Table 1
Baseline characteristics of a representative US adult population of 50 years and
older.
Participants
50þ years
Participants
50e70 years
Participants
70þ years
Participants, na 3577 2424 1153
Men, % 48.6 50.7 41.3
Age at survey, mean (SE) 61.8 (0.2) 57.6 (0.2) 76.2 (0.1)
Decedents, % 15.4 8.4 39.4
Ethnicity
Non-Hispanic white, % 79.1 77.7 84.1
Mexican American, % 3.9 4.2 2.9
Non-Hispanic black, % 8.2 8.7 6.7
Ethnicity other, % 8.8 9.5 6.3
Education level
<High school, % 22.3 19.1 33.1
High school, % 26.3 25.0 30.7
>High school, % 51.4 55.9 36.2
Household income level
<$20.000, % 20.1 16.1 33.9
$20.000e$65.000, % 49.0 48.0 52.3
>$65.000, % 30.9 35.9 13.8
Smoker, % 19.6 22.6 9.3
Average daily
physical activity
Sits a lot during the day, % 25.8 5.3 27.5
Stands or walks a
lot during the day, %
55.1 54.2 58.4
Lifts light loads during the day, % 14.8 15.4 12.7
Does heavy work or
carries heavy loads, %
4.3 5.1 1.4
BMI
<18.5 kg/m2, % 0.2 0.1 0.6
18.5e25.0 kg/m2, % 26.8 25.6 30.6
25.0e30.0 kg/m2, % 40.1 39.0 44.0
30.0 kg/m2, % 32.9 35.3 24.8
Body composition phenotypesb,c
LA-HM, % 23.4 23.2 23.9
LA-LM, % 25.7 26.1 24.4
HA-HM, % 26.9 27.4 25.3
HA-LM, % 24.0 23.4 26.4
TrFM/ASM centilesb,d
<15th centile, % 12.4 12.0 13.9
15e85th centile, % 71.9 72.4 70.3
85e95th centile, % 9.9 9.9 9.9
95 centile, % 5.8 5.7 5.9
FM/FFM centilesb,d
<15th centile, % 13.2 13.0 14.4
15e85th centile, % 70.6 71.2 68.7
85e95th centile, % 10.4 10.1 11.4
95 centile, % 5.7 5.6 5.5
Complex survey design is taken into account for calculating the baseline charac-
teristics, unless stated otherwise.
a Real observations, complex survey design is not taken into account.
b Multiple imputed data.
c LA is low adiposity, HA is high adiposity, LM is low adiposity and HM is high
muscle mass.
d TrFM is truncal fat mass, ASM is appendicular skeletal muscle mass, FM is fat
mass and FFM is fat free mass. The groups are formed based on specific body
composition ratio reference curves.
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association between time-to-event (e.g. mortality) and: (1) BMI;
and, (2) the three body composition models. The AFT models are
parametric models that assume a specific distribution, but do not
require the assumption of proportional hazards (i.e. for Cox
regression, which was not upheld in the data) [26]. Five different
AFT models were fit assuming different distributions for the base-
line hazard function (i.e. Weibull, exponential, Gamma, log-logistic
and log-normal) and model performance compared fit using the
Akaike Information Criterion (AIC) and Bayesian Information Cri-
terion (BIC). A final model assuming the log-normal distribution
best fitted the data for the BMI and each of the three DXA-models of
body composition phenotypes. If stratified analysis were performed
the log-logistic distribution fitted best for participants aged 50e70
years, and the exponential distribution for participants aged 70
years and older. Outcomes are expressed as time ratios (TR) with
95% confidence intervals (95% CI). Age at death or the year 2011was
used as the time-scale with age at baseline survey used as the entry
time [27]. Both uni-variable and multivariable models adjusting for
sex, ethnicity, education level, household income level, smoking
status and average daily physical activity were run to test the as-
sociation between body composition, defined by each model, with
survival time. For each model, the reference group included those
participants with a body composition that was assumed healthiest,
i.e. low fat mass and high muscle mass. All statistical analyses were
performed using the survey procedure of STATAversion 14.2, which
accounts for the complex sample design and DXA multiple impu-
tation procedure of the NHANES dataset.
3. Results
Baseline characteristics of the sample are shown in Table 1. The
total study population consisted of 3577 participants of 50 years
and older, of which 15.4% were deceased in 2011. The subgroup of
participants aged 50e69 years consisted of 2424 participants, of
which 8.4% were deceased in 2011. The subgroup of participants of
70 years and older consisted of 1153 participants, of which 39.4%
were deceased in 2011. The baseline characteristics of the 610
participants excluded from the analyses, because of missing data or
deceased within 24 months after the baseline survey, are shown in
Table 1 of the Online Supplementary Material. Overall, participants
had similar characteristics for age, BMI, socio-demographic factors
and prevalence of body composition phenotypes to the population
included in the main analysis.
The association between BMI category and survival years is
shown in Table 2. Therewas no significant association between BMI
and survival years for all participants. The same was observed for
the subgroup analysis of the age groups 50e70 years and 70 years
and older.
In Table 3 the association between the FM/FFM model and
survival is shown. There is no significant association for partici-
pants 50 years and older with a certain FM/FFM ratio and survival
years. The same was observed for the subgroup analysis of the
participants 50e70 years. In the subgroup analysis of the partici-
pants 70 years and older the participants with a FM/FFM ratio in the
15the85th centile (TR: 1.53; 95% CI: 1.01e2.33) had a significant
longer survival in comparison with the reference group.
The association between BC phenotype model and survival
years is shown in Table 4. Participants 50 years and older with LA-
LM (TR: 0.95; 95% CI: 0.92e0.99) and HA-LM (SO, TR: 0.96; 95% CI:
0.92e0.99) had a significantly shorter survival compared to the
participants with a LA-HM. The association became stronger in the
subgroup analysis for participants aged 50e70 years with LA-LM
(TR: 0.93; 95% CI: 0.88e0.98) and HA-LM (SO, TR: 0.92; 95% CI:
0.87e0.97). In addition, participants with a HA-HM had aPlease cite this article in press as: Van Aller C, et al., Sarcopenic obesity a
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HM (TR: 0.95; 95% CI: 0.90e1.00). In the subgroup analysis for
the participants aged 70 years and older the direction of the asso-
ciation changed. The participants with HA-HM (TR: 1.42; 95% CI:
1.07e1.89) survived significantly longer compared to the group
with LA-HM.
The association between TrFM/ASM model and survival years is
shown in Table 5. There is no significant association for participants
50 years and older with TrFM/ASM ratio and survival years when
adjusted for confounders. In the subgroup analysis the participants
50e70 years with a TrFM/ASM ratio in the 85the95th centile (TR:
0.91; 95% CI: 0.84e0.99) and above the 95th centile (SO, TR: 0.88;
95% CI: 0.81e0.95) had a significantly shorter survival compared tond overall mortality: Results from the application of novel models of
ination Survey 1999e2004, Clinical Nutrition (2018), https://doi.org/
Table 2
Time ratios (TR) for the association between BMI and survival years.
Participants  50 yearsa Participants 50e70 yearsb Participants  70 yearsc
TR 95% CI p-value TR 95% CI p-value TR 95% CI p-value
Crude model
BMI < 25 kg/m2 1.00 1.00 1.00
BMI 25e30 kg/m2 1.03 1.00e1.06 0.06 1.04 0.99e1.08 0.10 1.01 0.99e1.03 0.48
BMI  30 kg/m2 0.99 0.96e1.02 0.61 0.99 0.94e1.03 0.50 0.99 0.97e1.01 0.47
Adjusted modeld
BMI < 25 kg/m2 1.00 1.00 1.00
BMI 25e30 kg/m2 1.03 1.00e1.07 0.06 1.04 0.99e1.08 0.09 1.20 0.95e1.53 0.13
BMI  30 kg/m2 0.99 0.96e1.03 0.65 0.99 0.94e1.04 0.62 1.22 0.92e1.61 0.16
BMI is body mass index. Complex survey design is taken into account for calculating the TR.
a Accelerated failure time model analysis with lognormal distribution.
b Accelerated failure time model analysis with loglogistic distribution.
c Accelerated failure time model analysis with exponential distribution.
d Adjusted for sex, ethnicity, education level, household income level, smoking status and average daily physical activity.
Table 3
Time ratios (TR) for the association between FM/FFM ratio and survival years.
Participants  50 yearsa Participants 50e70 yearsb Participants  70 yearsc
TR 95% CI p-value TR 95% CI p-value TR 95% CI p-value
Crude model
<15th centile 1.00 1.00 1.00
15e84th centile 1.02 0.98e1.06 0.31 1.01 0.96e1.07 0.68 1.20 0.91e1.59 0.18
85e94th centile 1.01 0.96e1.06 0.70 0.98 0.92e1.05 0.58 1.44 0.94e2.19 0.09
>95th centile 0.99 0.93e1.05 0.66 0.96 0.90e1.03 0.24 1.12 0.71e1.76 0.62
Adjusted modeld
<15th centile 1.00 1.00 1.00
15e84th centile 1.01 0.97e1.06 0.54 0.99 0.93e1.05 0.81 1.28 0.96e1.71 0.09
85e94th centile 1.00 0.95e1.05 0.98 0.96 0.90e1.03 0.24 1.53 1.01e2.33 0.04
>95th centile 1.00 0.94e1.06 0.96 0.96 0.89e1.04 0.35 1.31 0.82e2.09 0.26
FM is fat mass and FFM is fat free mass. The groups are formed based on reference curves for the ratio between FM and FFM. Complex survey design is taken into account for
calculating the TR.
a Accelerated failure time model analysis with lognormal distribution.
b Accelerated failure time model analysis with loglogistic distribution.
c Accelerated failure time model analysis with exponential distribution.
d Adjusted for sex, ethnicity, education level, household income level, smoking status and average daily physical activity.
C. Van Aller et al. / Clinical Nutrition xxx (2018) 1e74the participants with a TrFM/ASM ratio below the 15th centile. In
the subgroup analysis of the participants 70 years and older the
direction of the association changed. Participants with a TrFM/ASM
ratio in the 15the85th (TR: 1.43; 95% CI: 1.14e1.79) had a signifi-
cantly longer survival in comparison with the reference group.
4. Discussion
This study showed that BMI did not predict increased or
decreased survival time in adults of 50 years and older. We showed
for the first time that the DXA based BC phenotype and TrFM/ASM
models significantly predicted survival time. However, the associ-
ation was age-dependent as the participants with SO was associ-
ated with lower survival time in participants of 50e70 years, but
not in participants older than 70 years of age.
Specifically, significant differences in survival time were found
between the body composition groups identified by the BC
phenotype and the TrFM/ASMmodels. Therefore, these twomodels
outperform BMI and the FM/FFM ratio model for the prediction of
survival time in this population. The performance of the BC
phenotype model could be explained by the use of ASM cut offs for
the identification of sarcopenia and possibly a better discrimination
of the body composition classes across the four different body
composition phenotypes (i.e., HA-HM, LA-HM, LA-LM, HA-LM). The
significant association of the TrFM/ASM model with survival time
may be explained by the inclusion of measures of central adiposity
and skeletal muscle mass; therefore, it could represent a more
informative model based on the stronger link of these twoPlease cite this article in press as: Van Aller C, et al., Sarcopenic obesity a
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10.1016/j.clnu.2018.01.022components with the pathogenesis of cardiovascular andmetabolic
diseases. ASM is a proxy measure of metabolic control, functional
performance and physical disability [28e30] and loss of ASM is
associated with poorer metabolic control and increased mortality
as well as impaired quality of life [31].
We found that the association between SO and survival time
were different in two age groups. The SO group aged 50e70 years
had the lowest survival if defined by the BC phenotype model and
TrFM/ASM ratio model. The SO group aged 70 years and older was
instead not associated with a decreased survival time according to
both models. The significant association of SO with increased
mortality risk in the age group 50e70 years confirmed results
found in other studies [12e18].
A recent study used the same NHANES 1999e2004 dataset to
evaluate the association between SO and risk of overall mortality
[18]. SO was defined by gender specific cut-off points for ASM and
FM and adopted a diagnostic approach similar to our BC phenotype
model. However, the two analyses were different for the choice of
age cut offs (50 years vs 60 years) and stratification of the an-
alyses (age- vs gender-stratified). A mid-life cut off point for age
(50 years) was chosen for our analyses based on the capacity of
our models to account for age in the identification of body
composition phenotypes and considering mid-life as a critical life
stage where ill health becomes the major cause of death, and the
number of mortality events progressively increases [32]. In addi-
tion, several other studies exploring the association between body
composition and health outcomes have used the same age cut off
point [16,33e41], and one of them conducted the same age-nd overall mortality: Results from the application of novel models of
ination Survey 1999e2004, Clinical Nutrition (2018), https://doi.org/
Table 5
Time ratios (TR) for the association between TrFM/ASM ratio and survival years.
Participants  50 yearsa Participants 50e70 yearsb Participants  70 yearsc
TR 95% CI p-value TR 95% CI p-value TR 95% CI p-value
Crude model
<15th centile 1.00 1.00 1.00
15e84th centile 1.01 0.97e1.04 0.65 0.98 0.93e1.03 0.47 1.34 1.07e1.67 0.01
85e94th centile 0.98 0.92e1.04 0.41 0.93 0.86e1.00 0.06 1.38 0.89e2.14 0.15
>95th centile 0.94 0.88e1.00 0.05 0.89 0.82e0.95 0.002 1.41 0.85e2.32 0.17
Adjusted modeld
<15th centile 1.00 1.00 1.00
15e84th centile 1.00 0.96e1.04 0.96 0.95 0.89e1.01 0.10 1.43 1.14e1.79 0.003
85e94th centile 0.98 0.92e1.04 0.43 0.91 0.84e0.99 0.03 1.44 0.91e2.28 0.11
>95th centile 0.95 0.89e1.01 0.09 0.88 0.81e0.95 0.002 1.61 0.98e2.66 0.06
TrFM is truncal fat mass and ASM is appendicular skeletal muscle mass. The groups are formed based on reference curves for the ratio between TrFM and ASM. Complex survey
design is taken into account for calculating the TR.
a Accelerated failure time model analysis with lognormal distribution.
b Accelerated failure time model analysis with loglogistic distribution.
c Accelerated failure time model analysis with exponential distribution.
d Adjusted for sex, ethnicity, education level, household income level, smoking status and average daily physical activity.
Table 4
Time ratios (TR) of the association between body composition phenotypes and survival years.
Participants  50 yearsa Participants 50e70 yearsb Participants  70 yearsc
TR 95% CI p-value TR 95% CI p-value TR 95% CI p-value
Crude model
LA-HM 1.00 1.00 1.00
LA-LM 0.95 0.92e0.99 0.008 0.94 0.89e0.99 0.01 0.94 0.72e1.23 0.64
HA-HM 0.99 0.96e1.02 0.59 0.96 0.92e1.01 0.10 1.34 1.00e1.80 0.04
HA-LM 0.95 0.92e0.99 0.01 0.92 0.87e0.98 0.007 1.05 0.78e1.41 0.76
Adjusted modeld
LA-HM 1.00 1.00 1.00
LA-LM 0.95 0.92e0.99 0.007 0.93 0.88e0.98 0.01 0.96 0.71e1.30 0.79
HA-HM 0.99 0.96e1.02 0.37 0.95 0.90e1.00 0.03 1.42 1.07e1.89 0.01
HA-LM 0.96 0.92e0.99 0.01 0.92 0.87e0.97 0.006 1.12 0.81e1.54 0.47
LA is low adiposity, HA is high adiposity, LM is low adiposity and HM is high muscle mass. Complex survey design is taken into account for calculating the TR.
a Accelerated failure time model analysis with lognormal distribution.
b Accelerated failure time model analysis with loglogistic distribution.
c Accelerated failure time model analysis with exponential distribution.
d Adjusted for sex, ethnicity, education level, household income level, smoking status and average daily physical activity.
C. Van Aller et al. / Clinical Nutrition xxx (2018) 1e7 5stratified analysis (<70 y and70 years) to evaluate the association
between SO and mortality [16]. Furthermore, we used AFT models
(with age as time scale and age at baseline survey as entry time) to
evaluate the association of SO with survival time since the pro-
portional hazard assumptions were not met. Despite the method-
ological differences, Batsis et al. [18] also observed a significant
increase in mortality risk associated with SO (only in men) and the
association was stronger for low lean body mass independent from
adiposity. This result could be explained by the age-dependent
effect of adiposity on risk of mortality that we observed in our
age-stratified analysis.
Other studies did not assess SO using DXA, but they used mid
arm circumference [12,17], or muscle function (walking speed [13];
hand grip/knee extensor strength [14e16]) to define sarcopenia.
Excess adiposity was defined by anthropometric measurements
including BMI [13,14,16] orWC [12,15,17]. However, the comparison
of results from the various studies is also complicated by the dif-
ferences in baseline age, sex distribution and duration of follow up;
three studies included male participants only with age between 45
and 79 years and follow up range between 6 and 30 years [12,14,17].
Other studies included both middle aged and older men and
women with age ranges between 50 and 91 years and follow up
duration between 5 and 33 years [15,16] and in one study partici-
pants aged between 65 and 102 years which were followed for 6
years [13]. Despite these differences, all these studies reported a
significant association of sarcopenia or SO with mortality risk and
our results are in line with these studies. Only one study [16]Please cite this article in press as: Van Aller C, et al., Sarcopenic obesity a
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10.1016/j.clnu.2018.01.022explored this age-interaction and, similar to our results, reported
an increased mortality risk in obese and normal-weight partici-
pants with low handgrip strength in the 50e69 age group whereas
overweight and obese participants aged 70 years and older with
high handgrip strength had significantly lower mortality than
normal-weight participants. This reversed prediction of adiposity
for disease and mortality risk as age increases is a documented
observation in epidemiological studies [16,42e45]. The “adiposity-
age paradox” is based on the notion that excess adiposity is one of
the causal steps in the pathogenesis of cardiovascular and meta-
bolic diseases at younger age but this predictive capacity progres-
sively disappears as people age with excess adiposity becoming a
protective factor [46].
A strength of this study is the large sample size of 3577 partic-
ipants and that body composition was analysed with DXA, which is
currently the preferred method for body composition assessment
based on the accuracy, repeatability and costs. In addition, the new
proposed DXAmodels allowed to control for the confounding effect
of age, sex and BMI on the assessment of the body composition
phenotypes. In addition, in the survival analysis age was used as
time scale instead of time on study. We also excluded individuals
who died in the first two years of follow up to minimise the in-
fluence of severe illnesses on body composition and mortality at
baseline. A limitation of this study is that people taller than 1.96 m
and heavier than 136 kg were excluded from the analysis, since
these people were not eligible for a DXA scan. A consequence of this
is that it may not be fully representative of other, more extremend overall mortality: Results from the application of novel models of
ination Survey 1999e2004, Clinical Nutrition (2018), https://doi.org/
C. Van Aller et al. / Clinical Nutrition xxx (2018) 1e76body composition phenotypes, such as individuals with morbid
obesity. A potential limitation of our approach to identify SO cases
is that it is based on the assessment of muscle mass without taking
into considerationmeasures of muscular function as recommended
in recent guidelines [47,48]. These recommendations follow from
findings that the important components of sarcopenia, low skeletal
muscle mass and low skeletal muscle function, are not always
directly associated and need to be identified separately. Although
the assessment of muscular function is key to assess disease and
mortality risk, our models aim primarily at improving the sensi-
tivity of DXA-derived measurements of body composition for dis-
ease risk prediction. Future studies need to identify to what extent
muscle function is able to improve mortality risk prediction based
on our body composition models. Our current analysis advanced
knowledge in the field by demonstrating a greater sensitivity of the
body composition phenotype model and the TrFM/ASM ratio to
predict mortality risk and observed that the sensitivity of the
models is age-dependent. Future research is warranted to evaluate
whether the addition of muscular function to the body composition
phenotype and the TrFM/ASM ratio models may improve disease
and mortality risk prediction. Another limitation is that body
composition was only measured at baseline, and the covariates of
the analysis were self-reported. Additionally, the follow-up period
was relatively short (7e12 years); however, this was the first study
that used the novel DXAmodels and, evenwith this relatively short
follow-up time, a significant association was found between body
composition and mortality risk.
In conclusion, the body composition phenotype model and the
TrFM/ASM ratio model are sensitive significant predictors of sur-
vival. The preferred model, for future research, should depend on
the research question. In addition, SO increases mortality risk in
people of 50e70 years, but not in people of 70 years and older. In
this group a relatively high FM and high muscle mass seem to be
beneficial. More research is needed into the understanding of age-
related differences in the association between body composition
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